Loading live market data…

Teva Pharmaceutical Industries Limited

NYSE:TEVA

$31.675 USD

-$0.14 (-0.46%)

Volume
1.97M
Average Volume
6.31M
Market Capitalization
$36.88B
P/E Ratio
23.11
Dividend Yield
0.00%
Price Target
$41.00
Year High
$37.35
Year Low
$14.99
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.01

TEVA Estimated and Actual Revenue by Quarter

TEVA Estimated and Actual EPS by Quarter

TEVA Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 3 675.81M 695.47M 685.15M 351.79M 362.02M 356.65M
2027-09-30 3 674.37M 693.98M 683.69M 351.04M 361.25M 355.89M
2027-06-30 3 630.75M 649.1M 639.47M 328.34M 337.89M 332.87M
2027-03-31 3 601.4M 618.9M 609.71M 313.06M 322.16M 317.38M
2026-12-31 5 641.51M 660.17M 650.38M 333.94M 343.65M 338.55M
2026-09-30 6 646.18M 656.79M 650.73M 336.36M 341.89M 338.73M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 3 1B 1.04B 1.02B 997.76M 1.03B 1.01B
2027-09-30 3 971.01M 1.01B 988.53M 995.62M 1.02B 1.01B
2027-06-30 3 809.57M 840.32M 824.18M 931.23M 958.32M 944.1M
2027-03-31 3 707.51M 734.38M 720.27M 887.9M 913.73M 900.17M
2026-12-31 5 844.19M 876.24M 859.42M 947.11M 974.67M 960.2M
2026-09-30 6 215.96M 1.05B 763.04M 954M 969.68M 960.72M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 3 4.42B 4.55B 4.48B 2 0.84921 0.88146 0.86453
2027-09-30 3 4.41B 4.54B 4.48B 2 0.82359 0.85487 0.83845
2027-06-30 3 4.13B 4.25B 4.19B 2 0.68666 0.71274 0.69905
2027-03-31 3 3.94B 4.05B 3.99B 2 0.60009 0.62288 0.61092
2026-12-31 5 4.2B 4.32B 4.26B 4 0.71602 0.74321 0.72894
2026-09-30 6 4.23B 4.3B 4.26B 6 0.18317 0.89141 0.64719